Similar articles

• Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?

  Oliveira MA, Bermudez JA, Chaves GC, Velásquez G. Oliveira MA, et al. Bull World Health Organ. 2004 Nov;82(11):815-21. Epub 2004 Dec 14. Bull World Health Organ. 2004. PMID: 15640916 Free PMC article.
• TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.

  't Hoen E. 't Hoen E. Chic J Int Law. 2002 Spring;3(1):27-46. Chic J Int Law. 2002. PMID: 15709298 No abstract available.
• TRIPS, pharmaceuticals, developing countries, and the Doha "solution".

  Sykes AO. Sykes AO. Chic J Int Law. 2002 Spring;3(1):47-68. Chic J Int Law. 2002. PMID: 15709299 No abstract available.
• Is Compulsory Licensing Bad for Public Health? Some Critical Comments on Drug Accessibility in Developing Countries.

  Guennif S. Guennif S. Appl Health Econ Health Policy. 2017 Oct;15(5):557-565. doi: 10.1007/s40258-017-0306-1. Appl Health Econ Health Policy. 2017. PMID: 28120166 Review.
• Patent Funded Access to Medicines.

  Andreassen T. Andreassen T. Dev World Bioeth. 2015 Dec;15(3):152-61. doi: 10.1111/dewb.12058. Epub 2014 Apr 21. Dev World Bioeth. 2015. PMID: 24750573 Review.